{"transactions":[{"id":4621412,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-09-17T20:30:11.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":103077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-394394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526394394/ownership.xml","form_type":"4"}},{"id":4621411,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:30:11.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":72.98,"value":72980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.54 to $73.52 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-394394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526394394/ownership.xml","form_type":"4"}},{"id":4621410,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-17T20:30:11.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-394394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526394394/ownership.xml","form_type":"4"}},{"id":683181,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-08-18T20:30:08.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":104077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-355561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526355561/ownership.xml","form_type":"4"}},{"id":683180,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:08.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":74.54,"value":74540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-355561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526355561/ownership.xml","form_type":"4"}},{"id":683179,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:08.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-355561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526355561/ownership.xml","form_type":"4"}},{"id":706647,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-07-17T20:15:02.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":105077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-307838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526307838/ownership.xml","form_type":"4"}},{"id":706646,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:15:02.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":71.17,"value":71170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-307838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526307838/ownership.xml","form_type":"4"}},{"id":706645,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-17T20:15:02.000Z","date":"2026-07-15","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-307838","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526307838/ownership.xml","form_type":"4"}},{"id":709762,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-07-14T20:15:02.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":false,"shares":24165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.63,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":24165},"source":{"system":"sec-edgar","filing":"0001193125-26-303188","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526303188/ownership.xml","form_type":"4"}},{"id":709761,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-14T20:15:02.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":24165,"price":75.16,"value":1816241.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.98 to $75.79 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-303188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526303188/ownership.xml","form_type":"4"}},{"id":709760,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-14T20:15:02.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":true,"shares":24165,"price":26.63,"value":643513.95,"ownership":{"direct":true},"balance_after":24165,"source":{"system":"sec-edgar","filing":"0001193125-26-303188","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526303188/ownership.xml","form_type":"4"}},{"id":723571,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":34699,"kind":"person","name":"Liu Brian Guan-Chyun","position":1,"cik":"0002007835","reported_name":"Liu Brian Guan-Chyun","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-29T21:26:56.000Z","date":"2026-06-25","kind":"purchase","planned":true,"acquired":true,"shares":371085,"price":66.87,"value":24814453.95,"ownership":{"direct":false,"nature":"By Seven Fleet Partners LP"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person, as the managing member of Seven Fleet Advisors, LLC, the investment manager of Seven Fleet Partners, LP, may be deemed to beneficially own the shares of Common Stock held by Seven Fleet Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1886236,"source":{"system":"sec-edgar","filing":"0001140361-26-026779","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000114036126026779/form4.xml","form_type":"4"}},{"id":726278,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-25T20:30:02.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":106077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-282861","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526282861/ownership.xml","form_type":"4"}},{"id":726277,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:30:02.000Z","date":"2026-06-24","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":70,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-282861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526282861/ownership.xml","form_type":"4"}},{"id":726276,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-25T20:30:02.000Z","date":"2026-06-24","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.6,"value":3000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001193125-26-282861","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526282861/ownership.xml","form_type":"4"}},{"id":728774,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-23T20:30:16.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":111077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-26-279543","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526279543/ownership.xml","form_type":"4"}},{"id":728773,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:16.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":65,"value":325000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-279543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526279543/ownership.xml","form_type":"4"}},{"id":728772,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-23T20:30:16.000Z","date":"2026-06-22","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.6,"value":3000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001193125-26-279543","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526279543/ownership.xml","form_type":"4"}},{"id":736193,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":1310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024."}],"balance_after":2620,"derivative":{"exercise_price":12.59,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":1310},"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736192,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":0,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736191,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":1310,"price":60.12,"value":78757.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736190,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":1310,"price":12.59,"value":16492.9,"ownership":{"direct":true},"balance_after":1310,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736189,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"sale","planned":true,"acquired":false,"shares":654,"price":60.12,"value":39318.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 27, 2026."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":736188,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T21:07:09.000Z","date":"2026-06-15","kind":"exercise","planned":true,"acquired":true,"shares":654,"price":3.72,"value":2432.88,"ownership":{"direct":true},"balance_after":654,"source":{"system":"sec-edgar","filing":"0001684531-26-000002","document":"form4-06162026_090604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000168453126000002/form4-06162026_090604.xml","form_type":"4"}},{"id":747330,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":34699,"kind":"person","name":"Liu Brian Guan-Chyun","position":1,"cik":"0002007835","reported_name":"Liu Brian Guan-Chyun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:19.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259700","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526259700/ownership.xml","form_type":"4"}},{"id":747328,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":20712,"kind":"person","name":"Tong Victor Edward Jr","position":1,"cik":"0002007923","reported_name":"Tong Victor Edward Jr","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:10.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312526259693/ownership.xml","form_type":"4"}},{"id":747941,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:09.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526259691/ownership.xml","form_type":"4"}},{"id":747714,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747713,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":116077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747712,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":54.5,"value":54500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747711,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 5, 2026"}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-26-259705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312526259705/ownership.xml","form_type":"4"}},{"id":747418,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":40790,"kind":"person","name":"Rossi Christina","position":1,"cik":"0001756941","reported_name":"Rossi Christina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:07.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756941/000119312526259690/ownership.xml","form_type":"4"}},{"id":747506,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":20763,"kind":"person","name":"Graf Susan E","position":1,"cik":"0001577637","reported_name":"Graf Susan E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-06-05T20:30:04.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":9354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the total number of shares of common stock subject to the option vest monthly following June 4, 2026, the date of grant (or, in the event the next annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of this stock option will vest on the date of such annual meeting of the Issuer's stockholders), subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":9354,"derivative":{"exercise_price":56.09,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":9354},"source":{"system":"sec-edgar","filing":"0001193125-26-259688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1577637/000119312526259688/ownership.xml","form_type":"4"}},{"id":804465,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-04-20T20:15:06.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":false,"shares":15600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":15600},"source":{"system":"sec-edgar","filing":"0001193125-26-164013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526164013/ownership.xml","form_type":"4"}},{"id":804464,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T20:15:06.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":15600,"price":73.01,"value":1138956.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $72.99 to $73.04, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-164013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526164013/ownership.xml","form_type":"4"}},{"id":804463,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T20:15:06.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":true,"shares":15600,"price":36.63,"value":571428.0,"ownership":{"direct":true},"balance_after":15600,"source":{"system":"sec-edgar","filing":"0001193125-26-164013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526164013/ownership.xml","form_type":"4"}},{"id":807334,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52288,"kind":"person","name":"Bellete Ambaw","position":1,"cik":"0002007090","reported_name":"Bellete Ambaw","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:13.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":107508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":107508,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":107508},"source":{"system":"sec-edgar","filing":"0001193125-26-159031","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007090/000119312526159031/ownership.xml","form_type":"4"}},{"id":807337,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52289,"kind":"person","name":"Kasturi Vijay","position":1,"cik":"0002007109","reported_name":"Kasturi Vijay","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:12.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":79216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":79216,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":79216},"source":{"system":"sec-edgar","filing":"0001193125-26-159030","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007109/000119312526159030/ownership.xml","form_type":"4"}},{"id":807138,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:10.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":45266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":45266,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":45266},"source":{"system":"sec-edgar","filing":"0001193125-26-159029","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000119312526159029/ownership.xml","form_type":"4"}},{"id":806836,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52231,"kind":"person","name":"DETORE JAMES M.","position":1,"cik":"0001623981","reported_name":"DETORE JAMES M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:04.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":90574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over a four-year period starting on April 15, 2026 (the \"Vesting Commencement Date\"), with 25% of the shares vesting on the date that is twelve months after the Vesting Commencement Date and the remainder vesting in thirty-six equal monthly installments over the subsequent three-year period."}],"balance_after":90574,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":90574},"source":{"system":"sec-edgar","filing":"0001193125-26-159025","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623981/000119312526159025/ownership.xml","form_type":"4"}},{"id":807338,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:02.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":271600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":271600,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":271600},"source":{"system":"sec-edgar","filing":"0001193125-26-159024","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000119312526159024/ownership.xml","form_type":"4"}},{"id":837973,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":1310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024."}],"balance_after":3930,"derivative":{"exercise_price":12.59,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":1310},"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837972,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":654,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837971,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":1310,"price":63.5,"value":83185.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837970,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":1310,"price":12.59,"value":16492.9,"ownership":{"direct":true},"balance_after":1310,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837969,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"sale","planned":true,"acquired":false,"shares":654,"price":63.5,"value":41529.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":837968,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T20:15:05.000Z","date":"2026-03-16","kind":"exercise","planned":true,"acquired":true,"shares":654,"price":3.72,"value":2432.88,"ownership":{"direct":true},"balance_after":654,"source":{"system":"sec-edgar","filing":"0001193125-26-110831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526110831/ownership.xml","form_type":"4"}},{"id":844185,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-13T20:09:24.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":64612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is currently vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.72,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":64612},"source":{"system":"sec-edgar","filing":"0002007101-26-000004","document":"form4-03132026_080321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000004/form4-03132026_080321.xml","form_type":"4"}},{"id":844184,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-13T20:09:24.000Z","date":"2026-03-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1847,"price":60.15,"value":111097.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The reporting person received 62,765 shares of common stock on net exercise of an option to purchase 64,612 shares of common stock. The Company withheld 1,847 shares of common stock underlying the option and the reporting person paid in cash the delta for payment in full of the aggregate exercise price. This transaction does not represent a sale by the reporting person."}],"balance_after":198916,"source":{"system":"sec-edgar","filing":"0002007101-26-000004","document":"form4-03132026_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000004/form4-03132026_080321.xml","form_type":"4"}},{"id":844183,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-13T20:09:24.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":64612,"price":1.72,"value":111132.64,"ownership":{"direct":true},"balance_after":200763,"source":{"system":"sec-edgar","filing":"0002007101-26-000004","document":"form4-03132026_080321.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000004/form4-03132026_080321.xml","form_type":"4"}},{"id":856199,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-03-06T22:52:13.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":false,"shares":102871,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is currently vested and exercisable."}],"balance_after":64612,"derivative":{"exercise_price":1.72,"expiration_date":"2031-04-18","underlying":"Common Stock","underlying_shares":102871},"source":{"system":"sec-edgar","filing":"0002007101-26-000002","document":"form4-03062026_100310.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000002/form4-03062026_100310.xml","form_type":"4"}},{"id":856198,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:52:13.000Z","date":"2026-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":2871,"price":61.61,"value":176882.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a \"net exercise\" of outstanding stock options. The reporting person received 100,000 shares of common stock on net exercise of an option to purchase 102,871 shares of common stock. The Company withheld 2,871 shares of common stock underlying the option and the reporting person paid in cash the delta for payment in full of the aggregate exercise price. This transaction does not represent a sale by the reporting person."}],"balance_after":136151,"source":{"system":"sec-edgar","filing":"0002007101-26-000002","document":"form4-03062026_100310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000002/form4-03062026_100310.xml","form_type":"4"}},{"id":856197,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52290,"kind":"person","name":"Kuan Arthur","position":1,"cik":"0002007101","reported_name":"Kuan Arthur","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-06T22:52:13.000Z","date":"2026-03-04","kind":"exercise","planned":false,"acquired":true,"shares":102871,"price":1.72,"value":176938.12,"ownership":{"direct":true},"balance_after":139022,"source":{"system":"sec-edgar","filing":"0002007101-26-000002","document":"form4-03062026_100310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007101/000200710126000002/form4-03062026_100310.xml","form_type":"4"}},{"id":940071,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":10491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024."}],"balance_after":5240,"derivative":{"exercise_price":12.59,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":10491},"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940070,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":false,"shares":654,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":1308,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":654},"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940069,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":10491,"price":52.99,"value":555918.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940068,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":10491,"price":12.59,"value":132081.69,"ownership":{"direct":true},"balance_after":10491,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940067,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"sale","planned":true,"acquired":false,"shares":654,"price":44.16,"value":28880.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":940066,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:15:07.000Z","date":"2026-01-09","kind":"exercise","planned":true,"acquired":true,"shares":654,"price":3.72,"value":2432.88,"ownership":{"direct":true},"balance_after":654,"source":{"system":"sec-edgar","filing":"0001193125-26-011756","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312526011756/ownership.xml","form_type":"4"}},{"id":986545,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":40790,"kind":"person","name":"Rossi Christina","position":1,"cik":"0001756941","reported_name":"Rossi Christina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-11-26T21:30:09.000Z","date":"2025-11-24","kind":"grant","planned":true,"acquired":true,"shares":20889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vest monthly following November 24, 2025, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":20889,"derivative":{"exercise_price":43.56,"expiration_date":"2035-11-23","underlying":"Common Stock","underlying_shares":20889},"source":{"system":"sec-edgar","filing":"0001193125-25-300645","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1756941/000119312525300645/ownership.xml","form_type":"4"}},{"id":995446,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-11-18T21:30:09.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":117077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-286228","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525286228/ownership.xml","form_type":"4"}},{"id":995445,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:30:09.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":41.43,"value":41430.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-286228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525286228/ownership.xml","form_type":"4"}},{"id":995444,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-18T21:30:09.000Z","date":"2025-11-17","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-286228","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525286228/ownership.xml","form_type":"4"}},{"id":1018324,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-15T20:15:03.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":118077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-240271","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525240271/ownership.xml","form_type":"4"}},{"id":1018323,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-15T20:15:03.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":43.25,"value":43250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-240271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525240271/ownership.xml","form_type":"4"}},{"id":1018322,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-15T20:15:03.000Z","date":"2025-10-13","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-240271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525240271/ownership.xml","form_type":"4"}},{"id":1020251,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-10T20:15:03.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":false,"shares":5903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023."}],"balance_after":1962,"derivative":{"exercise_price":3.72,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":5903},"source":{"system":"sec-edgar","filing":"0001193125-25-237104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525237104/ownership.xml","form_type":"4"}},{"id":1020250,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:15:03.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":5903,"price":43.99,"value":259672.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-237104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525237104/ownership.xml","form_type":"4"}},{"id":1020249,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-10T20:15:03.000Z","date":"2025-10-09","kind":"exercise","planned":true,"acquired":true,"shares":5903,"price":3.72,"value":21959.16,"ownership":{"direct":true},"balance_after":5903,"source":{"system":"sec-edgar","filing":"0001193125-25-237104","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525237104/ownership.xml","form_type":"4"}},{"id":1029164,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-10-01T21:07:18.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":119077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001193125-25-226964","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525226964/ownership.xml","form_type":"4"}},{"id":1029163,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-01T21:07:18.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":40.09,"value":200450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $40.00 to $40.20, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-226964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525226964/ownership.xml","form_type":"4"}},{"id":1029162,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-01T21:07:18.000Z","date":"2025-09-30","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":0.6,"value":3000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001193125-25-226964","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525226964/ownership.xml","form_type":"4"}},{"id":1030573,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-30T20:38:28.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":false,"shares":12755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":1.82,"expiration_date":"2031-07-18","underlying":"Common Stock","underlying_shares":12755},"source":{"system":"sec-edgar","filing":"0001193125-25-225133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525225133/ownership.xml","form_type":"4"}},{"id":1030572,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T20:38:28.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":12755,"price":39.19,"value":499868.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $38.99 to $39.41, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-225133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525225133/ownership.xml","form_type":"4"}},{"id":1030571,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-30T20:38:28.000Z","date":"2025-09-29","kind":"exercise","planned":true,"acquired":true,"shares":12755,"price":1.82,"value":23214.1,"ownership":{"direct":true},"balance_after":12755,"source":{"system":"sec-edgar","filing":"0001193125-25-225133","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525225133/ownership.xml","form_type":"4"}},{"id":1034521,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":false,"shares":3574,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":12755,"derivative":{"exercise_price":1.82,"expiration_date":"2031-07-18","underlying":"Common Stock","underlying_shares":3574},"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034520,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":false,"shares":19112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested"}],"balance_after":16329,"derivative":{"exercise_price":1.82,"expiration_date":"2031-07-18","underlying":"Common Stock","underlying_shares":19112},"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034519,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-19","kind":"sale","planned":true,"acquired":false,"shares":3574,"price":38.99,"value":139350.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034518,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-19","kind":"exercise","planned":true,"acquired":true,"shares":3574,"price":1.82,"value":6504.68,"ownership":{"direct":true},"balance_after":3574,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034517,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-18","kind":"sale","planned":true,"acquired":false,"shares":19112,"price":39.01,"value":745559.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $38.99 to $39.12, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1034516,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-22T11:30:03.000Z","date":"2025-09-18","kind":"exercise","planned":true,"acquired":true,"shares":19112,"price":1.82,"value":34783.84,"ownership":{"direct":true},"balance_after":19112,"source":{"system":"sec-edgar","filing":"0001193125-25-210015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000119312525210015/ownership.xml","form_type":"4"}},{"id":1039148,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-16T20:15:03.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":124077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001193125-25-205003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525205003/ownership.xml","form_type":"4"}},{"id":1039147,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:15:03.000Z","date":"2025-09-15","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":35.1,"value":35100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-25-205003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525205003/ownership.xml","form_type":"4"}},{"id":1039146,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-16T20:15:03.000Z","date":"2025-09-15","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001193125-25-205003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000119312525205003/ownership.xml","form_type":"4"}},{"id":1040082,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":34699,"kind":"person","name":"Liu Brian Guan-Chyun","position":1,"cik":"0002007835","reported_name":"Liu Brian Guan-Chyun","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T12:32:19.000Z","date":"2025-09-11","kind":"purchase","planned":true,"acquired":true,"shares":1515151,"price":33,"value":49999983.0,"ownership":{"direct":false,"nature":"By Seven Fleet Partners LP"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person, as the managing member of Seven Fleet Advisors, LLC, the investment manager of Seven Fleet Partners, LP, may be deemed to beneficially own the shares of Common Stock held by Seven Fleet Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose."}],"balance_after":1515151,"source":{"system":"sec-edgar","filing":"0001193125-25-202873","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000119312525202873/ownership.xml","form_type":"4"}},{"id":1045872,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":false,"shares":27015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully vested"}],"balance_after":0,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":27015},"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045871,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":3113,"price":33.22,"value":103413.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $33.06 to $33.56, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045870,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":7465,"price":32.64,"value":243657.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $32.06 to $33.05, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3113,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045869,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":4095,"price":31.42,"value":128664.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $31.01 to $31.98, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":10578,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045868,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"sale","planned":true,"acquired":false,"shares":12342,"price":30.47,"value":376060.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":14673,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1045867,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":30537,"kind":"person","name":"Mulay James","position":1,"cik":"0001684531","reported_name":"Mulay James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-08T20:16:22.000Z","date":"2025-09-05","kind":"exercise","planned":true,"acquired":true,"shares":27015,"price":0.6,"value":16209.0,"ownership":{"direct":true},"balance_after":27015,"source":{"system":"sec-edgar","filing":"0000950170-25-113556","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1684531/000095017025113556/ownership.xml","form_type":"4"}},{"id":1047419,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":28.99,"value":2899.0,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2903931,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047418,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":28.96,"value":2896.0,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2904031,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047417,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":30105,"price":28.24,"value":850165.2,"ownership":{"direct":false,"nature":"By Charming Jade Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2904131,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047416,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":75778,"kind":"person","name":"Song Hong Fang","position":1,"cik":"0002008157","reported_name":"Song Hong Fang","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T21:00:07.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":69695,"price":27.6,"value":1923582.0,"ownership":{"direct":false,"nature":"By Chaming Jade Limited"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein."}],"balance_after":2934236,"source":{"system":"sec-edgar","filing":"0002008157-25-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991792/000200815725000004/ownership.xml","form_type":"4"}},{"id":1047706,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-09-04T20:30:05.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":125077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001235862-25-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000123586225000003/ownership.xml","form_type":"4"}},{"id":1047705,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:30:05.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":28,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001235862-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000123586225000003/ownership.xml","form_type":"4"}},{"id":1047704,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-04T20:30:05.000Z","date":"2025-09-03","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":0.6,"value":600.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001235862-25-000003","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000123586225000003/ownership.xml","form_type":"4"}},{"id":1084594,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":22142,"kind":"person","name":"POST LEONARD E","position":1,"cik":"0001235862","reported_name":"POST LEONARD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-07-18T20:30:05.000Z","date":"2025-07-17","kind":"exercise","planned":true,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested"}],"balance_after":126077,"derivative":{"exercise_price":0.6,"expiration_date":"2028-07-08","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000950170-25-096949","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1235862/000095017025096949/ownership.xml","form_type":"4"}}],"next_cursor":"2025-07-18T20:30:05.000000Z,1084594"}